EP. 1: Introduction & Physiology of an Asthmatic Episode
Watch
EP. 2: Economic Burden and Type 2 Inflammation in Asthma
EP. 3: Diagnosis and Biomarkers Tested
EP. 4: Pharmacologic Treatment Options and Challenges
EP. 5: Recommended Guidelines and Restrictions in Asthma
EP. 6: Targeted Pathology and Associated Biomarkers in Asthma
EP. 7: Biomarkers–Diagnostic Tool for Optimal Therapy
EP. 8: Challenges of Biologics in the Treatment Plan
EP. 9: Uncontrolled Severe Asthma and Difference among Biologics
EP. 10: Omalizumab: Adverse effects, Mechanism, and Patient Factors
EP. 11: IL-5–Inhibiting Agents Mepolizumab, Benralizumab, and Reslizumab
EP. 12: Dupilumab: Mechanism, Dosing, and Pivotal Trials
EP. 13: Experience With Biologics and Pathways
EP. 14: Severe Patients and Final Thoughts